VYGR Earnings

Quarterly EPS
$-0.16
Q3 2024
$-0.59
Q4 2024
$-0.53
Q1 2025
$-0.57
Q2 2025
$-0.47
Q3 2025
$-0.47
Q4 2025
$-0.47
Q1 2026
$-0.40
Q2 2026
Latest Revenue3.2M
Latest Net Income-24473000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.403.2M-24473000-39.1%+29.8%
Q1 2026-$0.472.6M-27937000-59.9%+11.3%
Q4 2025-$0.4715.3M-27426000+144.3%+20.3%
Q3 2025-$0.4713.4M-27892000-45.7%-193.7%
Q2 2025-$0.575.2M-33382000-82.4%-216.7%
Q1 2025-$0.536.5M-31021000-66.8%-165.0%
Q4 2024-$0.596.3M-34487000-93.0%-146.1%
Q3 2024-$0.1624.6M-9044000+433.8%+72.9%
Q2 2024-$0.1829.6M-10141000
Q1 2024-$0.2019.5M-11330000
Q4 2023$1.2890.1M56.4M
Q3 2023-$0.594.6M-25901000
Voyager Therapeutics (VYGR) — Earnings